Ftse Mib
34.249,77
0,91%
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
NASDAQ Composite
15.927,90
2,03%
Bitcoin
63.169,38
-0,89%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Assistenza
Home Investire Azioni U.S.A. NASDAQ BioLineRx Ltd (BLRX) BioLineRx Ltd (BLRX) Notizie

BioLineRx Ltd

BLRX
0,6599
0,0846 (14,71%)
27 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
17/4/202413:00PRNUSBioLineRx Announces Poster Presentation on Apheresis Center..
04/3/202413:47EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/2/202413:08EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
16/2/202413:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
29/12/202322:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/12/202322:15EDGAR2Form F-3 - Registration statement by foreign private issuers
21/12/202313:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202313:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202313:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/11/202312:25IHMARKETNEWSMonday’s Wall Street Highlights: GM, Microsoft, Citigroup,..
01/11/202312:43PRNCABioLineRx a conclu un accord de licence exclusive pour le..
31/10/202314:00PRNCABioLineRx entered Exclusive License Agreement to..
26/10/202320:18EDGAR2Form SC 13D - General statement of acquisition of beneficial..
18/10/202323:07APSNew Collaboration Could Revolutionize Treatment of Chronic..
12/10/202313:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
28/9/202313:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202313:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/9/202313:00PRNUSBioLineRx Announces FDA Approval of APHEXDA™ (motixafortide)..
30/8/202313:16IHMARKETNEWSWednesday’s Wall Street Highlights: Ambarella, Alphabet,..
30/8/202313:15EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
30/8/202312:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/8/202323:25EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
17/7/202313:10EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
Apertura: 0,5614 Min: 0,5528 Max: 0,6216
Chiusura: 0,5753

La tua Cronologia

NASDAQ
BLRX
BioLineRx
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network